Co-morbidities and quality of life in elderly persons with haemophilia

British Journal of Haematology

Volumn 148, Issue 4, 2010, Pages 522-533

  Franchini, Massimo ^a   Mannucci, Pier Mannuccio ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Ageing; Cancer; Cardiovascular disease; Elderly; Haemophilia

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTHROMBIN COMPLEX; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTICOAGULANT AGENT; BEVACIZUMAB; CLOPIDOGREL; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; HEPARIN; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PEGINTERFERON; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9; RIBAVIRIN; RITUXIMAB; TRAMADOL;

ACUTE CORONARY SYNDROME; AGING; ARTHRODESIS; ARTHROPATHY; ARTHROPLASTY; BARE METAL STENT; BLEEDING; BLOOD TOXICITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CHRONIC PAIN; COLON CANCER; COMORBIDITY; CONTINUOUS INFUSION; DEPRESSION; DIALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG ELUTING STENT; DRUG WITHDRAWAL; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEMODIALYSIS; HEMOPHILIA; HEMOPHILIA A; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; JOINT PROSTHESIS; KIDNEY DISEASE; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER FAILURE; LOADING DRUG DOSE; MENTAL DISEASE; METASTASIS; MIXED INFECTION; MORTALITY; NONHODGKIN LYMPHOMA; NONHUMAN; PAIN; PERCUTANEOUS CORONARY INTERVENTION; PERITONEAL DIALYSIS; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REHABILITATION CARE; REVIEW; SIDE EFFECT; TREATMENT RESPONSE; WEIGHT REDUCTION;

AGED; AGING; CARDIOVASCULAR DISEASES; COMORBIDITY; HEMOPHILIA A; HUMANS; LIFE EXPECTANCY; MALE; NEOPLASMS; QUALITY OF LIFE;

EID: 75149188800     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08005.x     Document Type: Review

References (96)

1. Abshire, T. Kenet, G. (2004) Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. Journal of Thrombosis and Haemostasis, 2, 899 909.
2. Aledort, L.M., Haschmeyer, R.H. Pettersson, H. (1994) A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. Journal of Internal Medicine, 236, 391 399.
3. del Amo, J., Perez-Hoyos, S., Moreno, A., Quintana, M., Ruiz, I., Cisneros, J.M., Ferreros, I., González, C., García de Olalla, P., Pérez, R. Hernández, I. (2006) Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease. Journal of Acquired Immune Deficiency Syndromes, 41, 624 631.
4. Arnold, D.M., Julian, J.A. Walker, I.R. (2006) Association of Hemophilia Clinic Directors of Canada. Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up. Blood, 108, 460 464.
5. Bilora, F., Zanon, E., Petrobelli, F., Cavraro, M., Prandoni, P., Pagnan, A. Girolami, A. (2006) Does hemophilia protect against atherosclerosis? A case-control study. Clinical and Applied Thrombosis/Hemostasis, 12, 193 198.
6. Bovenzi, F., De Luca, L., Signore, N., Fusco, F. de Luca, I. (2003) Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Italian Heart Journal, 4, 728 730.
7. Brüggemann, L.W., Versteeg, H.H., Niers, T.M., Reitsma, P.H. Spek, C.A. (2008) Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. Journal of Cellular and Molecular Medicine, 12, 2622 2627.
8. Chorba, T.L., Homan, R.C., Clarke, M.J. Evatt, B.L. (2001) Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. American Journal of Haematology, 66, 229 240.
9. Coppola, A., Franchini, M. Tagliaferri, A. (2009) Prophylaxis in people with haemophilia. Thrombosis and Haemostasis, 101, 674 681.
10. Darby, S.C., Ewart, D.W., Giangrande, P.L., Spooner, R.J., Rizza, C.R., Dusheiko, G.M., Lee, C.A., Ludlam, C.A. Preston, F.E. (1997) Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet, 350, 1425 1431.
11. Darby, S.C., Kan, S.W., Spooner, R.J., Giangrande, P.L., Lee, C.A., Makris, M., Sabin, C.A., Watson, H.G., Wilde, J.T., Winter, M. UK Haemophilia Centre Doctors' Organisation. (2004a) The impact of HIV on mortality rates in the complete UK haemophilia population. AIDS, 18, 525 533.
12. Darby, S.C., Keeling, D.M., Spooner, R.J., Wan Kan, S., Giangrande, P.L., Collins, P.W., Hill, F.G., Hay, C.R. UK Haemophilia Centre Doctors' Organisation. (2004b) The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. Journal of Thrombosis and Haemostasis, 2, 1047 1054.
13. Darby, S.C., Kan, S.W., Spooner, R.J., Giangrande, P.L., Hill, F.G., Hay, C.R., Lee, C.A., Ludlam, C.A. Williams, M. (2007) Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood, 110, 815 825.
14. De Bels, D., Demeere, J.L., Dugauquier, J., Louis, P. Van der Vorst, E. (2004) Continuous infusion of factor VIIIc during heart surgery in a patient with haemophilia A. European Journal of Anaesthesiology, 21, 984 986.
15. Dimichele, D. Negrier, C. (2006) A retrospective postlicensure survey of FEIBA efficacy and safety. Haemophilia, 12, 352 362.
16. Dolan, G., Hermans, C., Klamroth, R., Madhok, R., Schutgens, R.E. Spengler, U. (2009) Challenges and controversies in haemophilia care in adulthood. Haemophilia, 15 (Suppl. 1 20 27.
17. Ewenstein, B.M., Takemoto, C., Warrier, I., Lusher, J., Saidi, P., Eisele, J., Ettinger, L.J. DiMichele, D. (1997) Nephrotic syndrome as a complication of immune tolerance in hemophilia B. Blood, 89, 1115 1116.
18. Fischer, K., Bom, J.G., Mauser-Bunschoten, E.P., Roosendaal, G. Berg, H.M. (2005) Effects of haemophilic arthropathy on health-related quality of life and socio-economic parameters. Haemophilia, 11, 43 48.
19. Franchini, M. (2004a) Thrombotic complications in patients with hereditary bleeding disorders. Thrombosis and Haemostasis, 92, 298 304. (Pubitemid 39172310)
20. Franchini, M. (2004b) Hepatitis C in haemophiliacs. Thrombosis and Haemostasis, 92, 1259 1268.
21. Franchini, M. Lippi, G. (2008) How I treat acquired FVIII inhibitors. Blood, 112, 250 255.
22. Franchini, M., Tagliaferri, A., Rossetti, G., Capra, F., Veneri, D., de Maria, E., Pattacini, C., Aprili, G. Gandini, G. (2002) Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment. Haemophilia, 8, 794 797.
23. Franchini, M., Salvagno, G.L. Lippi, G. (2006) Inhibitors in mild/moderate haemophilia A: an update. Thrombosis and Haemostasis, 96, 113 118.
24. Franchini, M., Tagliaferri, A. Mannucci, P.M. (2007) The management of hemophilia in elderly patients. Clinical Interventions in Aging, 2, 361 368.
25. Franchini, M., Mengoli, C., Veneri, D., Mazzi, R., Lippi, G. Cruciani, M. (2008a) Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis. Journal of Antimicrobial Chemotherapy, 61, 1191 1200.
26. Franchini, M., Mengoli, C., Lippi, G., Targher, G., Montagnana, M., Salvagno, G.L., Zaffanello, M. Cruciani, M. (2008b) Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis. Haemophilia, 14, 903 912.
27. Franchini, M., Lippi, G., Montagnana, M., Targher, G., Zaffanello, M., Salvagno, G.L., Rivolta, G.F., Perna, C.D. Tagliaferri, A. (2009) Haemophilia and cancer: a new challenge for hemophilia centers. Cancer Treatment Reviews, 35, 374 377.
28. Girolami, A., Randi, M.L., Ruzzon, E., Zanon, E. Girolami, B. (2005) Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in haemophilia B: a critical evaluation of reported cases. Journal of Thrombosis and Thrombolysis, 20, 43 46.
29. Girolami, A., Ruzzon, E., Fabris, F., Varvarikis, C., Sartori, R. Girolami, B. (2006) Myocardial infarction and other arterial occlusions in hemophilia A patients. Acta Haematologica, 116, 120 125.
30. Goedert, J.J., Eyster, M.E., Lederman, M.M., Mandalaki, T., De Moerloose, P., White, II., G.C., Angiolillo, A.L., Luban, N.L., Sherman, K.E., Manco-Johnson, M., Preiss, L., Leissinger, C., Kessler, C.M., Cohen, A.R., DiMichele, D., Hilgartner, M.W., Aledort, L.M., Kroner, B.L., Rosenberg, P.S. Hatzakis, A. (2002) End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood, 100, 1584 1589.
31. Gringeri, A., Mantovani, L. von Mackensen, S. (2006) Quality of life assessment in clinical practice in haemophilia treatment. Haemophilia, 12 (Suppl. 3 22 29.
32. Ikkala, E., Helske, T., Myllyla, G., Nevanlinna, H.R., Pitkänen, P. Rasi, V. (1982) Changes in the life expectancy of patients with severe hemophilia A in Finland in 1930-79. British Journal of Haematology, 52, 7 12.
33. Khallou-Laschet, J., Caligiuri, G., Tupin, E., Gaston, A.T., Poirier, B., Groyer, E., Urbain, D., Maisnier-Patin, S., Sarkar, R., Kaveri, S.V., Lacroix-Desmazes, S. Nicoletti, A. (2005) Role of the intrinsic coagulation pathway in atherogenesis assessed in hemophilic apolipoprotein E knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, e123 e126.
34. Konkle, B.A., Kessler, C., Aledort, L., Andersen, J., Fogarty, P., Kouides, P., Quon, D., Ragni, M., Zakarija, A. Ewenstein, B. (2009) Emerging clinical concerns in the ageing haemophilia patient. Haemophilia, DOI :.
35. Koumbarelis, E., Rosendaal, F.R., Gialeraki, A., Karafoulidou, A., Noteboom, W.M., Loizou, C., Panayotopoulou, C., Markakis, C. Mandalaki, T. (1994) Epidemiology of haemophilia in Greece: an overview. Thrombosis and Haemostasis, 72, 808 813.
36. Kulkarni, R., Soucie, J.M., Evatt, B. Hemophilia Surveillance System Project Investigators. (2003) Renal disease among males with haemophilia. Haemophilia, 9, 703 710.
37. Kulkarni, R., Soucie, J.M., Evatt, B.L. Hemophilia Surveillance System Project Investigators. (2005) Prevalence and risk factors for heart disease among males with hemophilia. American Journal of Hematology, 79, 36 42.
38. Lambert, C., Deneys, V., Pothen, D. Hermans, C. (2008) Safety of bevacizumab in mild haemophilia B. Thrombosis and Haemostasis, 99, 963 964.
39. Lambing, A., Kuriakose, P., Lanzon, J. Kachalsky, E. (2009) Dialysis in the haemophilia patient: a practical approach to care. Haemophilia, 15, 33 42.
40. Langer, F., Amirkhosravi, A., Ingersoll, S.B., Walker, J.M., Spath, B., Eifrig, B., Bokemeyer, C. Francis, J.L. (2006) Experimental metastasis and primary tumor growth in mice with hemophilia A. Journal of Thrombosis and Haemostasis, 4, 1056 1062.
41. Larsson, S.A. (1985) Life expecancy in Swedish hemophiliacs, 1831-1980. British Journal of Haematology, 59, 593 602.
42. Leebeek, F.W.G., Kappers-Klunne, M.C. Jie, K.S.G. (2004) Effective and safe use of recombinant factor VIIa (NovoSeven) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII. Haemophilia, 10, 250 253.
43. Liesner, R.J., Khair, K. Hann, I.M. (1996) The impact of prophylactic treatment on children with severe haemophilia. British Journal of Haematology, 92, 973 978.
44. Ludlam, C.A., Lee, R.J., Prescott, R.J., Andrews, J., Kirke, E., Thomas, A.E., Chalmers, E. Lowe, G.D. (2000) Haemophilia care in central Scotland 1980-94. I. Demographic characteristics, hospital admission and causes of death. Haemophilia, 6, 494 503.
45. MacKinlay, N., Taper, J., Renisson, F. Rickard, K. (2000) Cardiac surgery and catheterization in patients with haemophilia. Haemophilia, 6, 84 88.
46. Mafrici, A. Baudo, F. (2003) Hemophilia and percutaneous coronary interventions. Italian Heart Journal, 4, 731 733.
47. Makris, M., Preston, F.E., Rosendaal, F.R., Underwood, J.C., Rice, K.M. Triger, D.R. (1996) The natural history of chronic hepatitis C in haemophiliacs. British Journal of Haematology, 94, 746 752.
48. Manco-Johnson, M.J., Abshire, T.C., Shapiro, A.D., Riske, B., Hacker, M.R., Kilcoyne, R., Ingram, J.D., Manco-Johnson, M.L., Funk, S., Jacobson, L., Valentino, L.A., Hoots, W.K., Buchanan, G.R., DiMichele, D., Recht, M., Brown, D., Leissinger, C., Bleak, S., Cohen, A., Mathew, P., Matsunaga, A., Medeiros, D., Nugent, D., Thomas, G.A., Thompson, A.A., McRedmond, K., Soucie, J.M., Austin, H. Evatt, B.L. (2007) Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. New England Journal of Medicine, 357, 535 544.
49. Mancuso, M.E., Rumi, M.G., Santagostino, E., Linari, S., Coppola, A., Mannucci, P.M., Colombo, M. Hepatitis Study Group of the Association of Italian Hemophilia Centers (2006) High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C. Haematologica, 91, 1367 1371.
50. Mannucci, P.M. (1997) Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood, 90, 2515 2521.
51. Mannucci, P.M. (2008) Back to the future: a recent history of haemophilia treatment. Haemophilia, 14 (Suppl. 3 10 18.
52. Mannucci, P.M. Tuddenham, E.G. (2001) The hemophilias - from royal genes to gene therapy. New England Journal of Medicine, 344, 1773 1779.
53. Mauser-Bunschoten, E.P., Fransen Van De Putte, D.E. Schutgens, R.E.G. (2009) Co-morbidity in the ageing haemophilia: the down side of increased life expectancy. Haemophilia, 15, 853 863.
54. Mejia-Carvajal, C., Czapek, E.E. Valentino, L.A. (2006) Life expectancy in hemophilia outcome. Journal of Thrombosis and Haemostasis, 4, 507 509.
55. Miesbach, W., Alesci, S., Krekeler, S. Seifried, E. (2009) Comorbidities and bleeding pattern in elderly haemophilia A patients. Haemophilia, 15, 894 899.
56. Plug, I., van der Bom, J.G., Peters, M., Mauser-Bunschoten, E.P., De Goede-Bolder, A., Heijnen, L., Smit, C., Willemse, J. Rosendaal, F.R. (2006) Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. Journal of Thrombosis and Haemostasis, 4, 510 516.
57. Posthouwer, D., Plug, I., van der Bom, J.G., Fischer, K., Rosendaal, F.R. Mauser-Bunschoten, E.P. (2005) Hepatitis C and health-related quality of life among patients with hemophilia. Haematologica, 90, 846 850.
58. Posthouwer, D., Mauser-Bunschoten, E.P., Fischer, K. Makris, M. (2006) Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature. Haemophilia, 12, 473 478.
59. Posthouwer, D., Makris, M., Yee, T.T., Fischer, K., van Veen, J.J., Griffioen, A., van Erpecum, K.J. Mauser-Bunschoten, E.P. (2007a) Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood, 109, 3667 3671. (Pubitemid 46641713)
60. Posthouwer, D., Fischer, K., De Heusden, N. Mauser-Bunschoten, E.P. (2007b) Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience. Haemophilia, 13, 98 103.
61. Prentice, C.R., Lindsay, R.M., Barr, R.D., Forbes, C.D., Kennedy, A.C., McNicol, G.P. Douglas, A.S. (1971) Renal complications in haemophilia and Christmas disease. Quarterly Journal of Medicine, 40, 47 61.
62. Qurishi, N., Kreuzberg, C., Lüchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J.K. Spengler, U. (2003) Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet, 362, 708 713.
63. Ragni, M.V., Belle, S.H., Jaffe, R.A., Duerstein, S.L., Bass, D.C., McMillan, C.W., Lovrien, E.W., Aledort, L.M., Kisker, C.T. Stabler, S.P. (1993) Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia. Blood, 81, 1889 1897.
64. Ragni, M.V., Belle, S.H., Bass, D., Duerstein, S. Kingsley, L.A. (1998) Clinical characteristics and blood product usage in AIDS-associated lymphoma in haemophiliacs: a case-control study. Haemophilia, 4, 826 835.
65. Rattray, B., Nugent, D.J. Young, G. (2006) Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia, 12, 514 517.
66. Reitter, S., Waldhoer, T., Vutuc, C., Lechner, K. Pabinger, I. (2009) Survival in a cohort of patients with haemophilia at the haemophilia care center in Vienna, Austria, from 1983 to 2006. Haemophilia, 15, 888 893.
67. Rivolta, G.F., Di Perna, C., Franchini, M., Ippolito, L., Maurizio, A.R., Rocci, A. Tagliaferri, A. (2009a) Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis. Haemophilia, DOI :.
68. Rivolta, G.F., Di Perna, C., Franchini, M., Riccardi, F., Ippolito, L., Lombardi, M. Tagliaferri, A. (2009b) Successful immune tolerance induction with FVIII/VWF concentrate in an elderly severe haemophilia A patient with high responder inhibitor. Blood Transfusion, DOI :.
69. Rosendaal, F.R., Varekamp, I., Smit, C., Bröcker-Vriends, A.H., van Dijck, H., Vandenbroucke, J.P., Hermans, J., Suurmeijer, T.P. Briët, E. (1989) Mortality and causes of death in Dutch hemophiliacs, 1973-86. British Journal of Haematology, 71, 71 76.
70. Rumi, M.G., De Filippi, F., Santagostino, E. Colombo, M. (2004) Hepatitis C in haemophilia: lights and shadows. Haemophilia, 10 (Suppl. 4 211 215.
71. Santagostino, E., Colombo, M., Rivi, M., Rumi, M.G., Rocino, A., Linari, S., Mannucci, P.M. Study Group of the Association of Italian Hemophilia Centers. (2003) A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus. Blood, 102, 78 82.
72. Scalone, L., Mantovani, L.G., Mannucci, P.M., Gringeri, A. COCIS Study Investigators. (2006) Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia, 12, 154 162.
73. Schutgens, R.E.G., Tuinenburg, A., Roosendaal, G., Guyomi, S.H. Mauser-Bunschoten, E.P. (2009) Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline. Haemophilia, 15, 952 958.
74. Siboni, S.M., Mannucci, P.M., Gringeri, A., Franchini, M., Tagliaferri, A., Ferretti, M., Tradati, F.C., Santagostino, E., von Mackensen, S. Italian Association of Haemophilia Centres (AICE). (2009) Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. Journal of Thrombosis and Haemostasis, 7, 780 786.
75. Sikuler, E., Shnaider, A., Zilberman, D., Hilzenrat, N., Shemer-Avni, Y., Neumann, L. Buskila, D. (1997) Hepatitis C virus infection and extrahepatic malignancies. Journal of Clinical Gastroenterology, 24, 87 89.
76. Smit, C., Rosendaal, F.R., Varekamp, I., Bröcker-Vriends, A., Van Dijck, H., Suurmeijer, T.P. Briët, E. (1989) Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85. British Medical Journal, 298, 235 238.
77. Snyder, K.M. Kessler, C.M. (2008) The pivotal role of thrombin in cancer biology and tumorigenesis. Seminars in Thrombosis and Haemostasis, 34, 734 741.
78. Soucie, J.M., Nuss, R., Evatt, B., Abdelhak, A., Cowan, L., Hill, H., Kolakoski, M. Wilber, N. (2000) Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood, 96, 437 742.
79. Šrámek, A., Reiber, J.H., Gerrits, W.B. Rosendaal, F.R. (2001) Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation, 104, 762 767.
80. Šrámek, A., Kriek, M. Rosendaal, F.R. (2003) Decreased mortality of ischemic heart disease among carriers of hemophilia. Lancet, 362, 351 354.
81. Street, A., Hill, K., Sussex, B., Warner, M. Scully, M.F. (2006) Haemophilia and ageing. Haemophilia, 12 (Suppl. 3 8 12.
82. Szende, A., Schramm, W., Flood, E., Larson, P., Gorina, E., Rentz, A.M. Snyder, L. (2003) Health-related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instruments. Haemophilia, 9, 678 687.
83. Tagariello, G., Iorio, A., Santagostino, E., Morfini, M., Bisson, R., Innocenti, M., Mancuso, M.E., Mazzucconi, M.G., Pasta, G.L., Radossi, P., Rodorigo, G., Santoro, C., Sartori, R., Scaraggi, A., Solimeno, L.P., Mannucci, P.M. Italian Association Hemophilia Centre (AICE). (2009) Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. Blood, 114, 779 784.
84. Tagliaferri, A., Franchini, M., Rivolta, G., Iorio, A. Mannucci, P.M. (2008a) Causes of death among Italian hemophiliacs: results from the Italian Association of Hemophilia Centers (AICE) Survey. Haemophilia, 14 (Suppl. 2 141 (abs).
85. Tagliaferri, A., Franchini, M., Coppola, A., Rivolta, G.F., Santoro, C., Rossetti, G., Feola, G., Zanon, E., Dragani, A., Iannaccaro, P., Radossi, P. Mannucci, P.M. (2008b) Effects of secondary prophylaxis started in adolescent and adult haemophiliacs. Haemophilia, 14, 945 951.
86. Talaulikar, D., Shadbolt, B., McDonald, A. Pidcock, M. (2006) Health-related quality of life in chronic coagulation disorders. Haemophilia, 12, 633 642.
87. Thabut, D., Le Calvez, S., Thibault, V., Massard, J., Munteanu, M., Di Martino, V., Ratziu, V. Poynard, T. (2006) Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease? American Journal of Gastroenterology, 101, 1260 1267.
88. Toyoda, H., Fukuda, Y., Yokozaki, S., Hayashi, K., Saito, H. Takamatsu, J. (2001) Safety and complications of interventional radiology for hepatocellular carcinoma in patients with haemophilia and cirrhosis. British Journal of Haematology, 112, 1071 1073.
89. Tradati, F., Colombo, M., Mannucci, P.M., Rumi, M.G., De Fazio, C., Gamba, G., Ciavarella, N., Rocino, A., Morfini, M., Scaraggi, A. Taioli, E. (1998) A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood, 91, 1173 1177.
90. Triemstra, M., Rosendaal, F.R., Smit, C., Van der Ploeg, H.M. Briët, E. (1995) Mortality in patients with hemophilia: changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Annals of Internal Medicine, 123, 823 827.
91. Trippoli, S., Vaiani, M., Linari, S., Longo, G., Morfini, M. Messori, A. (2001) Multivariate analysis of factors influencing quality of life and utility in patients with haemophilia. Haematologica, 86, 722 728.
92. Tuinenburg, A. (2009) Cardiovascular disease in patients with hemophilia. Journal of Thrombosis and Haemostasis, 7, 247 254.
93. Walker, I.R. Julian, J.A., Association of Hemophilia Clinic Directors of Canada. (1998) Causes of death in Canadians with haemophilia 1980-1995. Haemophilia, 4, 714 720.
94. Wallny, T.A., Scholz, D.T., Oldenburg, J., Nicolay, C., Ezziddin, S., Pennekamp, P.H., Stoffel-Wagner, B. Kraft, C.N. (2007) Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia, 13, 79 84.
95. Walsh, M., Macgregor, D., Stuckless, S., Barrett, B., Kawaja, M. Scully, M.F. (2008) Health-related quality of life in a cohort of adult patients with mild hemophilia A. Journal of Thrombosis and Haemostasis, 6, 755 761.
96. Wilde, J.T., Lee, C.A., Darby, S.C., Kan, S.W., Giangrande, P., Phillips, A.N., Winter, M., Spooner, R., Ludlam, C.A. UK Haemophilia Centre Doctors' Organisation. (2002) The incidence of lymphoma in the UK haemophilia population between 1978 and 1999. AIDS, 16, 1803 1807.